Fibromyalgia Market Forecast

Fibromyalgia Market Forecast published by Datamonitor in June, 2009. This report price starts from US $ 15200.

Introduction

Abstract

Introduction

Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market for all current and future brands indicated for fibromyalgia. Datamonitor forecasts the fibromyalgia market to more than double in value from 2008 to total $2.5 billion by 2018 across the seven major regions.

Key reasons to purchase this research

• Quantify the current and future size of the fibromyalgia market
• Assess the impact of recent and anticipated events (patent expiries, new product launches, regulatory approval) on the fibromyalgia market
• Understand the country-specific impact of key events in the fibromyalgia market during the forecast period 2009 to 2018

Table of Contents

OVERVIEW

• This product contains forecasts for fibromyalgia drugs across the seven major markets from 2009 to 2018. It has been designed for delivery in an excel data pack format, but for more detail about this disease area please see the accompanying Forecast Insight: Fibromyalgia word document (DMHC2512).
  • The associated report can be found under Latest research in the Knowledge centre, through the search function or by contacting your sales representative.
  • Please select the data pack option from the download menu at the side of the page to access the model.
  • Introduction
  • Scope of this research
  • Research and analysis highlights
  • Key reasons to read this report
• Forecasting Methodology
  • The forecasting model:
  • General event information:
  • Event selection and quantification:
  • Event parameters:

Related Reports